Amgen news

The U.S. Court of Appeals for the Federal Circuit upheld a 1992 lower court ruling that dismissed a suit filed by Ortho Pharmaceutical Corp. against AMGN. The ruling upholds the Thousand Oaks, Calif., company's exclusive right to enforce its patents on erythropoietin.

The District Court granted AMGN's motion for summary judgment, dismissing the J&J suit for lack of standing, and concluding that AMGN alone has the right to enforce its EPO patents. ...